"Gaining some weight back is fine, but you just don't want to get back to the point that you were before you started the GLP-1s," Dr
Real-world data from the Cleveland Clinic found that a substantial share of patients maintained meaningful weight loss at one year, largely because many restarted their original medication or transitioned to an alternative obesity treatment
Standard pre-treatment screening includes thyroid ultrasound and labs, kidney function tests, blood sugar assessment, and review of personal and family cancer history
The article frames downstream metabolic markers such as fasting glucose, HbA1c, fasting insulin and the lipid panel as the practical read on whether therapy is working
Reported outcomes include improved glucose tolerance, enhanced insulin sensitivity, and protective effects on pancreatic beta cells, which are important factors in metabolic regulation